MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE

Clinical trials for MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE explained in plain language.

Never miss a new study

Get alerted when new MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE trials appear

Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

New Triple-Threat treatment tested for aggressive blood cancers

Disease control Ongoing

This study is testing a combination of three drugs—azacitidine, venetoclax, and pevonedistat—for adults newly diagnosed with certain high-risk blood cancers. These include acute myeloid leukemia (AML) that developed from other blood disorders or prior cancer treatment, as well as…

Matched conditions: MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Mar 30, 2026 14:28 UTC

MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE

Get alerted when new MYELOPROLIFERATIVE NEOPLASM, UNCLASSIFIABLE trials appear

New Triple-Threat treatment tested for aggressive blood cancers